First-in-human study of AMG 193, an MTA-cooperative PRMT5 inhibitor, in patients with MTAP-deleted solid tumors: results from phase I dose exploration ☆
Titel:
First-in-human study of AMG 193, an MTA-cooperative PRMT5 inhibitor, in patients with MTAP-deleted solid tumors: results from phase I dose exploration ☆
Auteur:
Rodon, J. Prenen, H. Sacher, A. Villalona-Calero, M. Penel, N. El Helali, A. Rottey, S. Yamamoto, N. Ghiringhelli, F. Goebeler, M.E. Doi, T. Postel-Vinay, S. Lin, C.-C. Liu, C. Chuang, C.-H. Keyvanjah, K. Eggert, T. O’Neil, B.H.